Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text
Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses | Journal of The Royal Society Interface
Study: 2 COVID vaccine doses much more effective than 1 against Delta | CIDRAP
COVID-19 Vaccine Information | County of Fresno
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
One vaccine dose is sufficient for immunity in COVID survivors, finds study
Testing fractional doses of COVID-19 vaccines | PNAS
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM
H-E-B | COVID-19 vaccine
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
What Happens If I Miss My Second Dose of COVID-19 Vaccine? | Houston Methodist On Health
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults | Nature
Should FDA Reconsider Allowing the Pooling of COVID-19 Vaccine Doses to Obtain Additional Doses? | Institute For Safe Medication Practices
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort? | KFF
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
